Physician profile
Sameer Ramesh Patel
NPI 1063469401
$1,114.41
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $214 · 2021: $14.46 · 2024: $19.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $187.75 | 2019-2020 | |
| Glaxosmithkline, LLC. | $149.93 | 2019-2020 | |
| Novo Nordisk INC | $149.21 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.22 | 2019-2020 | |
| Astellas Pharma US INC | $102.84 | 2019-2024 | Veozah |
| Philips North America LLC | $98.07 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $55.48 | 2019-2020 | |
| Amgen INC. | $54.22 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $39.92 | 2019 | |
| Valeritas, INC. | $32.97 | 2019 | |
| Janssen Pharmaceuticals, INC | $29.32 | 2019 | |
| Acadia Pharmaceuticals INC | $28.68 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $26.29 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $24.52 | 2019 | |
| Sanofi Pasteur INC. | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.